Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Emerson Electric Co’s stock clocked out at $133.93, down -4.72% from its previous closing price of $140.57. In other words, the price has decreased by -$4.72 from its previous closing price. On the day, 12.87 million shares were traded. EMR stock price reached its highest trading level at $134.38 during the session, while it also had its lowest trading level at $123.71.
Ratios:
To gain a deeper understanding of EMR’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 33.95 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.28. For the most recent quarter (mrq), Quick Ratio is recorded 0.63 and its Current Ratio is at 0.85. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.44.
Barclays Downgraded its Equal Weight to Underweight on March 10, 2025, whereas the target price for the stock was revised from $135 to $110.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 12 ’25 when Train Michael H. sold 28,305 shares for $119.44 per share. The transaction valued at 3,380,749 led to the insider holds 232,669 shares of the business.
Train Michael H. bought 28,305 shares of EMR for $3,379,476 on May 12 ’25. On May 08 ’25, another insider, Karsanbhai Surendralal Lanca, who serves as the President & CEO of the company, sold 16,698 shares for $113.33 each. As a result, the insider received 1,892,384 and left with 164,957 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EMR now has a Market Capitalization of 79070658560 and an Enterprise Value of 92200624128. As of this moment, Emerson’s Price-to-Earnings (P/E) ratio for their current fiscal year is 31.96, and their Forward P/E ratio for the next fiscal year is 20.52. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.63. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.24 while its Price-to-Book (P/B) ratio in mrq is 3.79. Its current Enterprise Value per Revenue stands at 5.237 whereas that against EBITDA is 18.999.
Stock Price History:
The Beta on a monthly basis for EMR is 1.30, which has changed by 0.28027916 over the last 52 weeks, in comparison to a change of 0.19283521 over the same period for the S&P500. Over the past 52 weeks, EMR has reached a high of $150.27, while it has fallen to a 52-week low of $90.06. The 50-Day Moving Average of the stock is -0.31%, while the 200-Day Moving Average is calculated to be 9.43%.
Shares Statistics:
It appears that EMR traded 3.10M shares on average per day over the past three months and 4686120 shares per day over the past ten days. A total of 562.80M shares are outstanding, with a floating share count of 561.20M. Insiders hold about 0.23% of the company’s shares, while institutions hold 82.98% stake in the company. Shares short for EMR as of 1752537600 were 11939878 with a Short Ratio of 3.85, compared to 1749772800 on 13361598. Therefore, it implies a Short% of Shares Outstanding of 11939878 and a Short% of Float of 2.1300000999999997.
Dividends & Splits
With its trailing 12-month dividend rate of 0.0, EMR has a forward annual dividend rate of 2.11. Against a Trailing Annual Dividend Yield of 0.0The stock’s 5-year Average Dividend Yield is 2.18. The current Payout Ratio is 61.25% for EMR, which recently paid a dividend on 2025-05-16 with an ex-dividend date of 2025-05-16. Stock splits for the company last occurred on 2006-12-12 when the company split stock in a 2:1 ratio.
Earnings Estimates
At present, 19.0 analysts are actively evaluating the performance of Emerson Electric Co (EMR) in the stock market.The consensus estimate for the next quarter is $1.49, with high estimates of $1.56 and low estimates of $1.41.
Analysts are recommending an EPS of between $6.03 and $5.95 for the fiscal current year, implying an average EPS of $5.99. EPS for the following year is $6.5, with 27.0 analysts recommending between $6.65 and $6.1.
Revenue Estimates
In the current quarter, 16 analysts expect revenue to total $4.87B. It ranges from a high estimate of $4.98B to a low estimate of $4.39B. As of the current estimate, Emerson Electric Co’s year-ago sales were $4.62BFor the next quarter, 16 analysts are estimating revenue of $4.47B. There is a high estimate of $4.67B for the next quarter, whereas the lowest estimate is $4.4B.
A total of 19 analysts have provided revenue estimates for EMR’s current fiscal year. The highest revenue estimate was $18.22B, while the lowest revenue estimate was $18.04B, resulting in an average revenue estimate of $18.11B. In the same quarter a year ago, actual revenue was $17.49BBased on 26 analysts’ estimates, the company’s revenue will be $19.02B in the next fiscal year. The high estimate is $19.43B and the low estimate is $18.17B.
